AstraZeneca is one of only a handful of pure-play biopharmaceutical companies which is headquartered in London, United Kingdom. It is the world’s seventh-largest pharmaceutical company measured by 2012 prescription drug sales and has operations in over 100 countries. The company was founded in 1999 through the merger of the Sweden-based Astra AB and the UK-based Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). They employ around 57,500 people worldwide: 32.7% in Europe, 23.5% in North America, 6.1% in Central and South America, 4.2% in the Middle East and Africa and 33.5% in Asia Pacific.
Their primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). They are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.THey are one of few companies to span the entire life-cycle of a medicine from research and development to manufacturing and supply, and the global commercialisation of primary care and speciality care medicines.
- Unimax and many more
|Type||Public Limited Company|
|Traded as||LSE: AZN
|Founded||6 April 1999|
|Headquarters||London, United Kingdom|
|Key people||Leif Johansson (Chairman)
Pascal Soriot (CEO)
|Revenue||US$26.095 billion (2014)|
|Net income||US$1.235 billion (2014)|
|Number of employees||50,000 (2014)|